Public Profile

ADVANZ PHARMA Corp. Limited

ADVANZ PHARMA Corp. Limited, headquartered in Great Britain, is a prominent player in the pharmaceutical industry, specialising in the development and commercialisation of specialty and generic medicines. Founded in 2018, the company has rapidly established itself across key operational regions, including Europe and North America, focusing on therapeutic areas such as oncology, neurology, and infectious diseases. With a commitment to providing high-quality, accessible healthcare solutions, ADVANZ PHARMA offers a diverse portfolio of products that stand out for their efficacy and safety. The company has achieved significant milestones, including strategic partnerships and a growing market presence, positioning itself as a trusted provider in the pharmaceutical landscape. Through innovation and a patient-centric approach, ADVANZ PHARMA continues to enhance its reputation and impact within the healthcare sector.

DitchCarbon Score

How does ADVANZ PHARMA Corp. Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

13

Industry Average

Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

2

Industry Benchmark

ADVANZ PHARMA Corp. Limited's score of 13 is higher than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.

80%

ADVANZ PHARMA Corp. Limited's reported carbon emissions

ADVANZ PHARMA Corp. Limited, headquartered in Great Britain, currently does not have publicly available carbon emissions data or specific reduction targets. As a result, there are no reported figures for their Scope 1, 2, or 3 emissions. The company has not outlined any formal climate commitments or initiatives aimed at reducing carbon emissions. In the context of the pharmaceutical industry, it is increasingly important for companies to establish clear climate strategies and reduction goals to align with global sustainability efforts. Without specific data or commitments, ADVANZ PHARMA's position on climate action remains unclear.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. ADVANZ PHARMA Corp. Limited's primary industry is Chemicals nec, which is medium in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. ADVANZ PHARMA Corp. Limited is headquartered in GB, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

ADVANZ PHARMA Corp. Limited is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

Aquestive Therapeutics, Inc.

US
Chemicals nec
Updated 5 days ago

Ipsen

FR
Medical, precision and optical instruments, watches and clocks (33)
Updated 5 days ago

DMK Pharmaceuticals Corporation

US
Chemicals nec
Updated 5 days ago

Teva Pharmaceuticals

IL
Chemicals nec
Updated 3 days ago

Collegium Pharmaceutical, Inc.

US
Chemicals nec
Updated 5 days ago

Lannett Company, Inc.

US
Chemicals nec
Updated 5 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers